nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—ABCB1—esophageal cancer	0.377	1	CbGaD
Captopril—ACE—thoracic aorta—esophageal cancer	0.0304	0.165	CbGeAlD
Captopril—Scald—Methotrexate—esophageal cancer	0.022	0.134	CcSEcCtD
Captopril—Irreversible renal failure—Cisplatin—esophageal cancer	0.0147	0.0893	CcSEcCtD
Captopril—LTA4H—exocrine gland—esophageal cancer	0.0127	0.0692	CbGeAlD
Captopril—SLC22A6—Methotrexate—esophageal cancer	0.0105	0.335	CbGbCtD
Captopril—REN—exocrine gland—esophageal cancer	0.00984	0.0534	CbGeAlD
Captopril—MMP2—exocrine gland—esophageal cancer	0.00904	0.0491	CbGeAlD
Captopril—ALB—Methotrexate—esophageal cancer	0.00893	0.285	CbGbCtD
Captopril—Thermal burn—Methotrexate—esophageal cancer	0.00727	0.0441	CcSEcCtD
Captopril—ABCB1—Cisplatin—esophageal cancer	0.0072	0.23	CbGbCtD
Captopril—REN—neck—esophageal cancer	0.00629	0.0342	CbGeAlD
Captopril—MMP2—neck—esophageal cancer	0.00578	0.0314	CbGeAlD
Captopril—LTA4H—bronchus—esophageal cancer	0.00546	0.0297	CbGeAlD
Captopril—LTA4H—smooth muscle tissue—esophageal cancer	0.00534	0.029	CbGeAlD
Captopril—Renal failure chronic—Cisplatin—esophageal cancer	0.00516	0.0313	CcSEcCtD
Captopril—MMP9—neck—esophageal cancer	0.00503	0.0273	CbGeAlD
Captopril—LTA4H—trachea—esophageal cancer	0.0049	0.0266	CbGeAlD
Captopril—ABCB1—Methotrexate—esophageal cancer	0.00467	0.149	CbGbCtD
Captopril—F2—neck—esophageal cancer	0.00439	0.0238	CbGeAlD
Captopril—REN—epithelium—esophageal cancer	0.00428	0.0232	CbGeAlD
Captopril—LTA4H—digestive system—esophageal cancer	0.00422	0.0229	CbGeAlD
Captopril—REN—smooth muscle tissue—esophageal cancer	0.00412	0.0224	CbGeAlD
Captopril—MMP2—epithelium—esophageal cancer	0.00393	0.0214	CbGeAlD
Captopril—MMP2—bronchus—esophageal cancer	0.00387	0.021	CbGeAlD
Captopril—MMP2—smooth muscle tissue—esophageal cancer	0.00379	0.0206	CbGeAlD
Captopril—LTA4H—lung—esophageal cancer	0.00352	0.0191	CbGeAlD
Captopril—MMP2—trachea—esophageal cancer	0.00348	0.0189	CbGeAlD
Captopril—MMP9—epithelium—esophageal cancer	0.00342	0.0186	CbGeAlD
Captopril—Obstructive airways disorder—Methotrexate—esophageal cancer	0.00336	0.0204	CcSEcCtD
Captopril—MMP9—smooth muscle tissue—esophageal cancer	0.0033	0.0179	CbGeAlD
Captopril—REN—digestive system—esophageal cancer	0.00326	0.0177	CbGeAlD
Captopril—MMP2—digestive system—esophageal cancer	0.00299	0.0163	CbGeAlD
Captopril—F2—epithelium—esophageal cancer	0.00299	0.0162	CbGeAlD
Captopril—REN—lung—esophageal cancer	0.00272	0.0148	CbGeAlD
Captopril—ACE—neck—esophageal cancer	0.00268	0.0146	CbGeAlD
Captopril—MMP9—digestive system—esophageal cancer	0.0026	0.0141	CbGeAlD
Captopril—SLC15A1—epithelium—esophageal cancer	0.00254	0.0138	CbGeAlD
Captopril—MMP2—lung—esophageal cancer	0.0025	0.0136	CbGeAlD
Captopril—Rales—Capecitabine—esophageal cancer	0.0025	0.0151	CcSEcCtD
Captopril—LTA4H—lymph node—esophageal cancer	0.00241	0.0131	CbGeAlD
Captopril—Diabetic—Methotrexate—esophageal cancer	0.00228	0.0138	CcSEcCtD
Captopril—F2—digestive system—esophageal cancer	0.00227	0.0123	CbGeAlD
Captopril—Anuria—Methotrexate—esophageal cancer	0.00218	0.0132	CcSEcCtD
Captopril—MMP9—lung—esophageal cancer	0.00217	0.0118	CbGeAlD
Captopril—SLC15A1—digestive system—esophageal cancer	0.00194	0.0105	CbGeAlD
Captopril—F2—lung—esophageal cancer	0.0019	0.0103	CbGeAlD
Captopril—Rales—Methotrexate—esophageal cancer	0.00186	0.0113	CcSEcCtD
Captopril—ACE—epithelium—esophageal cancer	0.00182	0.0099	CbGeAlD
Captopril—Necrosis—Cisplatin—esophageal cancer	0.00177	0.0107	CcSEcCtD
Captopril—ACE—smooth muscle tissue—esophageal cancer	0.00176	0.00954	CbGeAlD
Captopril—Ageusia—Cisplatin—esophageal cancer	0.00172	0.0104	CcSEcCtD
Captopril—MMP2—lymph node—esophageal cancer	0.00171	0.00929	CbGeAlD
Captopril—Loss of libido—Methotrexate—esophageal cancer	0.00165	0.01	CcSEcCtD
Captopril—Liver injury—Cisplatin—esophageal cancer	0.00165	0.01	CcSEcCtD
Captopril—MMP9—lymph node—esophageal cancer	0.00149	0.00808	CbGeAlD
Captopril—Ulcer—Cisplatin—esophageal cancer	0.00147	0.0089	CcSEcCtD
Captopril—Blister—Capecitabine—esophageal cancer	0.00142	0.00861	CcSEcCtD
Captopril—Hepatocellular injury—Cisplatin—esophageal cancer	0.00139	0.00842	CcSEcCtD
Captopril—ACE—digestive system—esophageal cancer	0.00139	0.00754	CbGeAlD
Captopril—Hyperkalaemia—Cisplatin—esophageal cancer	0.00137	0.00827	CcSEcCtD
Captopril—Body temperature increased—Carboplatin—esophageal cancer	0.00134	0.0081	CcSEcCtD
Captopril—Ageusia—Capecitabine—esophageal cancer	0.00126	0.00766	CcSEcCtD
Captopril—Proteinuria—Capecitabine—esophageal cancer	0.00117	0.00707	CcSEcCtD
Captopril—ACE—lung—esophageal cancer	0.00116	0.00629	CbGeAlD
Captopril—Protein urine present—Capecitabine—esophageal cancer	0.00115	0.00697	CcSEcCtD
Captopril—Polyuria—Cisplatin—esophageal cancer	0.00115	0.00696	CcSEcCtD
Captopril—Haemolytic anaemia—Cisplatin—esophageal cancer	0.00112	0.00677	CcSEcCtD
Captopril—Renal failure acute—Cisplatin—esophageal cancer	0.00109	0.00662	CcSEcCtD
Captopril—Ulcer—Capecitabine—esophageal cancer	0.00108	0.00656	CcSEcCtD
Captopril—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.00104	0.00632	CcSEcCtD
Captopril—Cerebrovascular accident—Cisplatin—esophageal cancer	0.00103	0.00624	CcSEcCtD
Captopril—Blood pressure increased—Capecitabine—esophageal cancer	0.00102	0.00621	CcSEcCtD
Captopril—Hyponatraemia—Cisplatin—esophageal cancer	0.00101	0.00614	CcSEcCtD
Captopril—Necrosis—Methotrexate—esophageal cancer	0.000972	0.00589	CcSEcCtD
Captopril—Dry eye—Capecitabine—esophageal cancer	0.000946	0.00573	CcSEcCtD
Captopril—Urine output increased—Capecitabine—esophageal cancer	0.000926	0.00561	CcSEcCtD
Captopril—Orthostatic hypotension—Cisplatin—esophageal cancer	0.000921	0.00558	CcSEcCtD
Captopril—Proteinuria—Methotrexate—esophageal cancer	0.000868	0.00526	CcSEcCtD
Captopril—Protein urine present—Methotrexate—esophageal cancer	0.000856	0.00519	CcSEcCtD
Captopril—Diabetes mellitus—Capecitabine—esophageal cancer	0.000855	0.00518	CcSEcCtD
Captopril—Pancreatitis—Cisplatin—esophageal cancer	0.000855	0.00518	CcSEcCtD
Captopril—Photosensitivity—Capecitabine—esophageal cancer	0.000847	0.00513	CcSEcCtD
Captopril—Polyuria—Capecitabine—esophageal cancer	0.000847	0.00513	CcSEcCtD
Captopril—ALB—lymph node—esophageal cancer	0.000828	0.0045	CbGeAlD
Captopril—Pancytopenia—Cisplatin—esophageal cancer	0.000828	0.00502	CcSEcCtD
Captopril—Oliguria—Methotrexate—esophageal cancer	0.000827	0.00501	CcSEcCtD
Captopril—Glossitis—Methotrexate—esophageal cancer	0.000827	0.00501	CcSEcCtD
Captopril—Haemolytic anaemia—Capecitabine—esophageal cancer	0.000824	0.00499	CcSEcCtD
Captopril—Ulcer—Methotrexate—esophageal cancer	0.000806	0.00489	CcSEcCtD
Captopril—Renal failure acute—Capecitabine—esophageal cancer	0.000805	0.00488	CcSEcCtD
Captopril—ACE—lymph node—esophageal cancer	0.000793	0.0043	CbGeAlD
Captopril—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.000788	0.00478	CcSEcCtD
Captopril—Vasculitis—Methotrexate—esophageal cancer	0.000781	0.00474	CcSEcCtD
Captopril—Dermatitis bullous—Capecitabine—esophageal cancer	0.000778	0.00472	CcSEcCtD
Captopril—Renal failure—Cisplatin—esophageal cancer	0.000764	0.00463	CcSEcCtD
Captopril—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000759	0.0046	CcSEcCtD
Captopril—Stomatitis—Cisplatin—esophageal cancer	0.000758	0.00459	CcSEcCtD
Captopril—Hyponatraemia—Capecitabine—esophageal cancer	0.000747	0.00452	CcSEcCtD
Captopril—Cardiac arrest—Capecitabine—esophageal cancer	0.000707	0.00429	CcSEcCtD
Captopril—Ataxia—Capecitabine—esophageal cancer	0.000699	0.00424	CcSEcCtD
Captopril—Urine output increased—Methotrexate—esophageal cancer	0.000689	0.00418	CcSEcCtD
Captopril—Gynaecomastia—Methotrexate—esophageal cancer	0.000682	0.00413	CcSEcCtD
Captopril—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000679	0.00412	CcSEcCtD
Captopril—CYP2D6—digestive system—esophageal cancer	0.000679	0.00369	CbGeAlD
Captopril—Muscular weakness—Capecitabine—esophageal cancer	0.000656	0.00397	CcSEcCtD
Captopril—Lymphadenopathy—Methotrexate—esophageal cancer	0.000649	0.00393	CcSEcCtD
Captopril—Flushing—Cisplatin—esophageal cancer	0.000648	0.00393	CcSEcCtD
Captopril—ABCB1—epithelium—esophageal cancer	0.000642	0.00349	CbGeAlD
Captopril—Diabetes mellitus—Methotrexate—esophageal cancer	0.000636	0.00386	CcSEcCtD
Captopril—Bronchospasm—Capecitabine—esophageal cancer	0.000632	0.00383	CcSEcCtD
Captopril—Photosensitivity—Methotrexate—esophageal cancer	0.00063	0.00382	CcSEcCtD
Captopril—Polyuria—Methotrexate—esophageal cancer	0.00063	0.00382	CcSEcCtD
Captopril—Angina pectoris—Capecitabine—esophageal cancer	0.000626	0.00379	CcSEcCtD
Captopril—Alopecia—Cisplatin—esophageal cancer	0.000617	0.00374	CcSEcCtD
Captopril—Pancytopenia—Capecitabine—esophageal cancer	0.00061	0.0037	CcSEcCtD
Captopril—Neutropenia—Capecitabine—esophageal cancer	0.000601	0.00364	CcSEcCtD
Captopril—Renal failure acute—Methotrexate—esophageal cancer	0.0006	0.00363	CcSEcCtD
Captopril—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000587	0.00356	CcSEcCtD
Captopril—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000587	0.00356	CcSEcCtD
Captopril—Weight decreased—Capecitabine—esophageal cancer	0.000581	0.00352	CcSEcCtD
Captopril—Vision blurred—Cisplatin—esophageal cancer	0.000573	0.00347	CcSEcCtD
Captopril—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000572	0.00347	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000568	0.00344	CcSEcCtD
Captopril—ABCB1—trachea—esophageal cancer	0.000568	0.00308	CbGeAlD
Captopril—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000565	0.00342	CcSEcCtD
Captopril—Ill-defined disorder—Cisplatin—esophageal cancer	0.000564	0.00342	CcSEcCtD
Captopril—Renal failure—Capecitabine—esophageal cancer	0.000563	0.00341	CcSEcCtD
Captopril—Anaemia—Cisplatin—esophageal cancer	0.000561	0.0034	CcSEcCtD
Captopril—Stomatitis—Capecitabine—esophageal cancer	0.000559	0.00339	CcSEcCtD
Captopril—Jaundice—Capecitabine—esophageal cancer	0.000559	0.00339	CcSEcCtD
Captopril—Malaise—Cisplatin—esophageal cancer	0.000548	0.00332	CcSEcCtD
Captopril—Agranulocytosis—Capecitabine—esophageal cancer	0.000535	0.00324	CcSEcCtD
Captopril—Ataxia—Methotrexate—esophageal cancer	0.00052	0.00315	CcSEcCtD
Captopril—Myalgia—Cisplatin—esophageal cancer	0.000517	0.00313	CcSEcCtD
Captopril—Rhinitis—Capecitabine—esophageal cancer	0.000516	0.00313	CcSEcCtD
Captopril—Hepatitis—Capecitabine—esophageal cancer	0.000514	0.00312	CcSEcCtD
Captopril—Discomfort—Cisplatin—esophageal cancer	0.000511	0.0031	CcSEcCtD
Captopril—Pharyngitis—Capecitabine—esophageal cancer	0.000511	0.00309	CcSEcCtD
Captopril—Anaphylactic shock—Cisplatin—esophageal cancer	0.000496	0.003	CcSEcCtD
Captopril—ABCB1—digestive system—esophageal cancer	0.000488	0.00265	CbGeAlD
Captopril—Erythema multiforme—Capecitabine—esophageal cancer	0.000486	0.00295	CcSEcCtD
Captopril—Thrombocytopenia—Cisplatin—esophageal cancer	0.000485	0.00294	CcSEcCtD
Captopril—Tachycardia—Cisplatin—esophageal cancer	0.000484	0.00293	CcSEcCtD
Captopril—Flushing—Capecitabine—esophageal cancer	0.000477	0.00289	CcSEcCtD
Captopril—Eosinophilia—Methotrexate—esophageal cancer	0.000474	0.00287	CcSEcCtD
Captopril—Anorexia—Cisplatin—esophageal cancer	0.000473	0.00286	CcSEcCtD
Captopril—Pancreatitis—Methotrexate—esophageal cancer	0.000469	0.00284	CcSEcCtD
Captopril—Hypotension—Cisplatin—esophageal cancer	0.000463	0.00281	CcSEcCtD
Captopril—Alopecia—Capecitabine—esophageal cancer	0.000455	0.00275	CcSEcCtD
Captopril—Pancytopenia—Methotrexate—esophageal cancer	0.000454	0.00275	CcSEcCtD
Captopril—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000452	0.00274	CcSEcCtD
Captopril—Neutropenia—Methotrexate—esophageal cancer	0.000447	0.00271	CcSEcCtD
Captopril—Paraesthesia—Cisplatin—esophageal cancer	0.000445	0.0027	CcSEcCtD
Captopril—Dyspnoea—Cisplatin—esophageal cancer	0.000442	0.00268	CcSEcCtD
Captopril—Erectile dysfunction—Methotrexate—esophageal cancer	0.000441	0.00267	CcSEcCtD
Captopril—Dysgeusia—Capecitabine—esophageal cancer	0.000439	0.00266	CcSEcCtD
Captopril—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000437	0.00265	CcSEcCtD
Captopril—Decreased appetite—Cisplatin—esophageal cancer	0.000431	0.00261	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000423	0.00256	CcSEcCtD
Captopril—Vision blurred—Capecitabine—esophageal cancer	0.000422	0.00256	CcSEcCtD
Captopril—Renal failure—Methotrexate—esophageal cancer	0.000419	0.00254	CcSEcCtD
Captopril—Stomatitis—Methotrexate—esophageal cancer	0.000416	0.00252	CcSEcCtD
Captopril—Ill-defined disorder—Capecitabine—esophageal cancer	0.000415	0.00252	CcSEcCtD
Captopril—Anaemia—Capecitabine—esophageal cancer	0.000414	0.00251	CcSEcCtD
Captopril—Feeling abnormal—Cisplatin—esophageal cancer	0.000409	0.00248	CcSEcCtD
Captopril—ABCB1—lung—esophageal cancer	0.000408	0.00222	CbGeAlD
Captopril—Malaise—Capecitabine—esophageal cancer	0.000404	0.00245	CcSEcCtD
Captopril—Syncope—Capecitabine—esophageal cancer	0.000402	0.00243	CcSEcCtD
Captopril—Agranulocytosis—Methotrexate—esophageal cancer	0.000398	0.00241	CcSEcCtD
Captopril—Palpitations—Capecitabine—esophageal cancer	0.000396	0.0024	CcSEcCtD
Captopril—Loss of consciousness—Capecitabine—esophageal cancer	0.000394	0.00239	CcSEcCtD
Captopril—Body temperature increased—Cisplatin—esophageal cancer	0.000392	0.00238	CcSEcCtD
Captopril—Cough—Capecitabine—esophageal cancer	0.000391	0.00237	CcSEcCtD
Captopril—Hepatitis—Methotrexate—esophageal cancer	0.000383	0.00232	CcSEcCtD
Captopril—Arthralgia—Capecitabine—esophageal cancer	0.000381	0.00231	CcSEcCtD
Captopril—Chest pain—Capecitabine—esophageal cancer	0.000381	0.00231	CcSEcCtD
Captopril—Myalgia—Capecitabine—esophageal cancer	0.000381	0.00231	CcSEcCtD
Captopril—Pharyngitis—Methotrexate—esophageal cancer	0.00038	0.0023	CcSEcCtD
Captopril—Discomfort—Capecitabine—esophageal cancer	0.000377	0.00228	CcSEcCtD
Captopril—Dry mouth—Capecitabine—esophageal cancer	0.000373	0.00226	CcSEcCtD
Captopril—Confusional state—Capecitabine—esophageal cancer	0.000368	0.00223	CcSEcCtD
Captopril—Erythema multiforme—Methotrexate—esophageal cancer	0.000362	0.00219	CcSEcCtD
Captopril—Shock—Capecitabine—esophageal cancer	0.00036	0.00218	CcSEcCtD
Captopril—Thrombocytopenia—Capecitabine—esophageal cancer	0.000358	0.00217	CcSEcCtD
Captopril—Tachycardia—Capecitabine—esophageal cancer	0.000357	0.00216	CcSEcCtD
Captopril—Asthenia—Cisplatin—esophageal cancer	0.000356	0.00216	CcSEcCtD
Captopril—Anorexia—Capecitabine—esophageal cancer	0.000348	0.00211	CcSEcCtD
Captopril—Hypotension—Capecitabine—esophageal cancer	0.000341	0.00207	CcSEcCtD
Captopril—Diarrhoea—Cisplatin—esophageal cancer	0.000339	0.00206	CcSEcCtD
Captopril—Alopecia—Methotrexate—esophageal cancer	0.000338	0.00205	CcSEcCtD
Captopril—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000333	0.00202	CcSEcCtD
Captopril—Insomnia—Capecitabine—esophageal cancer	0.000331	0.002	CcSEcCtD
Captopril—Paraesthesia—Capecitabine—esophageal cancer	0.000328	0.00199	CcSEcCtD
Captopril—Dysgeusia—Methotrexate—esophageal cancer	0.000326	0.00198	CcSEcCtD
Captopril—Dyspnoea—Capecitabine—esophageal cancer	0.000326	0.00197	CcSEcCtD
Captopril—Dyspepsia—Capecitabine—esophageal cancer	0.000322	0.00195	CcSEcCtD
Captopril—Decreased appetite—Capecitabine—esophageal cancer	0.000318	0.00193	CcSEcCtD
Captopril—Vomiting—Cisplatin—esophageal cancer	0.000315	0.00191	CcSEcCtD
Captopril—Fatigue—Capecitabine—esophageal cancer	0.000315	0.00191	CcSEcCtD
Captopril—Vision blurred—Methotrexate—esophageal cancer	0.000314	0.0019	CcSEcCtD
Captopril—Rash—Cisplatin—esophageal cancer	0.000313	0.00189	CcSEcCtD
Captopril—Constipation—Capecitabine—esophageal cancer	0.000313	0.00189	CcSEcCtD
Captopril—Dermatitis—Cisplatin—esophageal cancer	0.000312	0.00189	CcSEcCtD
Captopril—Ill-defined disorder—Methotrexate—esophageal cancer	0.000309	0.00187	CcSEcCtD
Captopril—Anaemia—Methotrexate—esophageal cancer	0.000308	0.00187	CcSEcCtD
Captopril—Feeling abnormal—Capecitabine—esophageal cancer	0.000301	0.00183	CcSEcCtD
Captopril—Malaise—Methotrexate—esophageal cancer	0.000301	0.00182	CcSEcCtD
Captopril—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000299	0.00181	CcSEcCtD
Captopril—Nausea—Cisplatin—esophageal cancer	0.000294	0.00178	CcSEcCtD
Captopril—Cough—Methotrexate—esophageal cancer	0.000291	0.00176	CcSEcCtD
Captopril—Abdominal pain—Capecitabine—esophageal cancer	0.000289	0.00175	CcSEcCtD
Captopril—Body temperature increased—Capecitabine—esophageal cancer	0.000289	0.00175	CcSEcCtD
Captopril—Chest pain—Methotrexate—esophageal cancer	0.000284	0.00172	CcSEcCtD
Captopril—Myalgia—Methotrexate—esophageal cancer	0.000284	0.00172	CcSEcCtD
Captopril—Arthralgia—Methotrexate—esophageal cancer	0.000284	0.00172	CcSEcCtD
Captopril—Discomfort—Methotrexate—esophageal cancer	0.00028	0.0017	CcSEcCtD
Captopril—ABCB1—lymph node—esophageal cancer	0.000279	0.00152	CbGeAlD
Captopril—Confusional state—Methotrexate—esophageal cancer	0.000274	0.00166	CcSEcCtD
Captopril—Anaphylactic shock—Methotrexate—esophageal cancer	0.000272	0.00165	CcSEcCtD
Captopril—Thrombocytopenia—Methotrexate—esophageal cancer	0.000266	0.00161	CcSEcCtD
Captopril—Asthenia—Capecitabine—esophageal cancer	0.000262	0.00159	CcSEcCtD
Captopril—Anorexia—Methotrexate—esophageal cancer	0.000259	0.00157	CcSEcCtD
Captopril—Pruritus—Capecitabine—esophageal cancer	0.000259	0.00157	CcSEcCtD
Captopril—Hypotension—Methotrexate—esophageal cancer	0.000254	0.00154	CcSEcCtD
Captopril—Diarrhoea—Capecitabine—esophageal cancer	0.00025	0.00152	CcSEcCtD
Captopril—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000248	0.0015	CcSEcCtD
Captopril—Insomnia—Methotrexate—esophageal cancer	0.000246	0.00149	CcSEcCtD
Captopril—Paraesthesia—Methotrexate—esophageal cancer	0.000244	0.00148	CcSEcCtD
Captopril—Dyspnoea—Methotrexate—esophageal cancer	0.000243	0.00147	CcSEcCtD
Captopril—Somnolence—Methotrexate—esophageal cancer	0.000242	0.00147	CcSEcCtD
Captopril—Dizziness—Capecitabine—esophageal cancer	0.000242	0.00146	CcSEcCtD
Captopril—Dyspepsia—Methotrexate—esophageal cancer	0.000239	0.00145	CcSEcCtD
Captopril—Decreased appetite—Methotrexate—esophageal cancer	0.000236	0.00143	CcSEcCtD
Captopril—Fatigue—Methotrexate—esophageal cancer	0.000235	0.00142	CcSEcCtD
Captopril—Vomiting—Capecitabine—esophageal cancer	0.000232	0.00141	CcSEcCtD
Captopril—Rash—Capecitabine—esophageal cancer	0.00023	0.0014	CcSEcCtD
Captopril—Dermatitis—Capecitabine—esophageal cancer	0.00023	0.0014	CcSEcCtD
Captopril—Headache—Capecitabine—esophageal cancer	0.000229	0.00139	CcSEcCtD
Captopril—Feeling abnormal—Methotrexate—esophageal cancer	0.000224	0.00136	CcSEcCtD
Captopril—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000222	0.00135	CcSEcCtD
Captopril—Nausea—Capecitabine—esophageal cancer	0.000217	0.00132	CcSEcCtD
Captopril—Abdominal pain—Methotrexate—esophageal cancer	0.000215	0.0013	CcSEcCtD
Captopril—Body temperature increased—Methotrexate—esophageal cancer	0.000215	0.0013	CcSEcCtD
Captopril—Asthenia—Methotrexate—esophageal cancer	0.000195	0.00118	CcSEcCtD
Captopril—Pruritus—Methotrexate—esophageal cancer	0.000192	0.00117	CcSEcCtD
Captopril—Diarrhoea—Methotrexate—esophageal cancer	0.000186	0.00113	CcSEcCtD
Captopril—Dizziness—Methotrexate—esophageal cancer	0.00018	0.00109	CcSEcCtD
Captopril—Vomiting—Methotrexate—esophageal cancer	0.000173	0.00105	CcSEcCtD
Captopril—Rash—Methotrexate—esophageal cancer	0.000172	0.00104	CcSEcCtD
Captopril—Dermatitis—Methotrexate—esophageal cancer	0.000171	0.00104	CcSEcCtD
Captopril—Headache—Methotrexate—esophageal cancer	0.00017	0.00103	CcSEcCtD
Captopril—Nausea—Methotrexate—esophageal cancer	0.000162	0.000979	CcSEcCtD
Captopril—LTA4H—Metabolism—EP300—esophageal cancer	7.43e-05	0.000307	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—ANXA1—esophageal cancer	7.43e-05	0.000307	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ELMO1—esophageal cancer	7.41e-05	0.000306	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—CREBBP—esophageal cancer	7.41e-05	0.000306	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—PTGS2—esophageal cancer	7.39e-05	0.000305	CbGpPWpGaD
Captopril—F2—Signaling Pathways—WIF1—esophageal cancer	7.38e-05	0.000305	CbGpPWpGaD
Captopril—CYP2D6—Metapathway biotransformation—CYP19A1—esophageal cancer	7.34e-05	0.000303	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CXCL2—esophageal cancer	7.26e-05	0.000299	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	7.25e-05	0.000299	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AKAP13—esophageal cancer	7.24e-05	0.000299	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—SST—esophageal cancer	7.23e-05	0.000298	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	7.17e-05	0.000296	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—ATP4A—esophageal cancer	7.17e-05	0.000296	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—GHRL—esophageal cancer	7.04e-05	0.000291	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	6.87e-05	0.000283	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CSNK1A1—esophageal cancer	6.81e-05	0.000281	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—EP300—esophageal cancer	6.78e-05	0.00028	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—ANXA1—esophageal cancer	6.75e-05	0.000278	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HIST1H2BM—esophageal cancer	6.69e-05	0.000276	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PDE4D—esophageal cancer	6.63e-05	0.000273	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	6.57e-05	0.000271	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—SST—esophageal cancer	6.56e-05	0.000271	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—EGFR—esophageal cancer	6.55e-05	0.00027	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	6.55e-05	0.00027	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	6.46e-05	0.000266	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—GHRL—esophageal cancer	6.4e-05	0.000264	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PFN1—esophageal cancer	6.37e-05	0.000263	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	6.36e-05	0.000263	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—GNG7—esophageal cancer	6.3e-05	0.00026	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	6.28e-05	0.000259	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	6.28e-05	0.000259	CbGpPWpGaD
Captopril—F2—G alpha (q) signalling events—PIK3CA—esophageal cancer	6.27e-05	0.000259	CbGpPWpGaD
Captopril—F2—Hemostasis—NOS2—esophageal cancer	6.25e-05	0.000258	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	6.25e-05	0.000258	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—ERBB2—esophageal cancer	6.2e-05	0.000256	CbGpPWpGaD
Captopril—ALB—Hemostasis—CFL1—esophageal cancer	6.04e-05	0.000249	CbGpPWpGaD
Captopril—MMP9—Axon guidance—EGFR—esophageal cancer	6.03e-05	0.000249	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	6.02e-05	0.000248	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—XIAP—esophageal cancer	5.91e-05	0.000244	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.78e-05	0.000238	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ELMO1—esophageal cancer	5.72e-05	0.000236	CbGpPWpGaD
Captopril—ALB—Hemostasis—GNG7—esophageal cancer	5.7e-05	0.000235	CbGpPWpGaD
Captopril—F2—Hemostasis—CREBBP—esophageal cancer	5.61e-05	0.000231	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	5.61e-05	0.000231	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AKAP13—esophageal cancer	5.59e-05	0.000231	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CTNNA1—esophageal cancer	5.58e-05	0.00023	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CXCL2—esophageal cancer	5.55e-05	0.000229	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	5.55e-05	0.000229	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TP53—esophageal cancer	5.53e-05	0.000228	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PIK3CA—esophageal cancer	5.5e-05	0.000227	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	5.48e-05	0.000226	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	5.45e-05	0.000225	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—ABCC2—esophageal cancer	5.43e-05	0.000224	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PSME1—esophageal cancer	5.19e-05	0.000214	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PSME2—esophageal cancer	5.19e-05	0.000214	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HIST1H2BM—esophageal cancer	5.16e-05	0.000213	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ANXA1—esophageal cancer	5.16e-05	0.000213	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PDE4D—esophageal cancer	5.12e-05	0.000211	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—EP300—esophageal cancer	5.04e-05	0.000208	CbGpPWpGaD
Captopril—F2—Hemostasis—NOS3—esophageal cancer	5.02e-05	0.000207	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SST—esophageal cancer	5.02e-05	0.000207	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.99e-05	0.000206	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—GNG7—esophageal cancer	4.93e-05	0.000203	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—GHRL—esophageal cancer	4.89e-05	0.000202	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NOTCH3—esophageal cancer	4.89e-05	0.000202	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GNG7—esophageal cancer	4.87e-05	0.000201	CbGpPWpGaD
Captopril—ALB—Metabolism—BLVRB—esophageal cancer	4.84e-05	0.0002	CbGpPWpGaD
Captopril—ALB—Metabolism—SLC52A3—esophageal cancer	4.84e-05	0.0002	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FBXW7—esophageal cancer	4.81e-05	0.000199	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	4.76e-05	0.000196	CbGpPWpGaD
Captopril—ALB—Hemostasis—HSPA5—esophageal cancer	4.64e-05	0.000192	CbGpPWpGaD
Captopril—F2—Signaling Pathways—XIAP—esophageal cancer	4.56e-05	0.000188	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NOTCH2—esophageal cancer	4.39e-05	0.000181	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	4.33e-05	0.000179	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	4.32e-05	0.000178	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CTNNA1—esophageal cancer	4.31e-05	0.000178	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—EGFR—esophageal cancer	4.3e-05	0.000177	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CXCL2—esophageal cancer	4.29e-05	0.000177	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	4.27e-05	0.000176	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	4.25e-05	0.000175	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SLC52A3—esophageal cancer	4.24e-05	0.000175	CbGpPWpGaD
Captopril—ABCB1—Metabolism—BLVRB—esophageal cancer	4.24e-05	0.000175	CbGpPWpGaD
Captopril—ALB—Metabolism—SLC10A2—esophageal cancer	4.12e-05	0.00017	CbGpPWpGaD
Captopril—ALB—Metabolism—CA1—esophageal cancer	4.12e-05	0.00017	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PSME2—esophageal cancer	4e-05	0.000165	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PSME1—esophageal cancer	4e-05	0.000165	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLC52A3—esophageal cancer	4e-05	0.000165	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—BLVRB—esophageal cancer	4e-05	0.000165	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ANXA1—esophageal cancer	3.99e-05	0.000164	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TGFBR2—esophageal cancer	3.89e-05	0.000161	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SST—esophageal cancer	3.88e-05	0.00016	CbGpPWpGaD
Captopril—F2—Hemostasis—EP300—esophageal cancer	3.82e-05	0.000158	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GHRL—esophageal cancer	3.78e-05	0.000156	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NOTCH3—esophageal cancer	3.78e-05	0.000156	CbGpPWpGaD
Captopril—ALB—Metabolism—CA2—esophageal cancer	3.77e-05	0.000155	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FBXW7—esophageal cancer	3.72e-05	0.000153	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.71e-05	0.000153	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SMAD4—esophageal cancer	3.69e-05	0.000152	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.68e-05	0.000152	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	3.67e-05	0.000151	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CA1—esophageal cancer	3.61e-05	0.000149	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SLC10A2—esophageal cancer	3.61e-05	0.000149	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	3.56e-05	0.000147	CbGpPWpGaD
Captopril—ALB—Metabolism—PLCE1—esophageal cancer	3.5e-05	0.000145	CbGpPWpGaD
Captopril—ALB—Metabolism—ADH7—esophageal cancer	3.5e-05	0.000145	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	3.48e-05	0.000144	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.46e-05	0.000143	CbGpPWpGaD
Captopril—ALB—Hemostasis—ABL1—esophageal cancer	3.44e-05	0.000142	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CA1—esophageal cancer	3.4e-05	0.00014	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLC10A2—esophageal cancer	3.4e-05	0.00014	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NOTCH2—esophageal cancer	3.39e-05	0.00014	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CA2—esophageal cancer	3.3e-05	0.000136	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	3.15e-05	0.00013	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CA2—esophageal cancer	3.11e-05	0.000128	CbGpPWpGaD
Captopril—ALB—Metabolism—ADH1B—esophageal cancer	3.07e-05	0.000127	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PLCE1—esophageal cancer	3.07e-05	0.000127	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ADH7—esophageal cancer	3.07e-05	0.000127	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	3.04e-05	0.000126	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HIF1A—esophageal cancer	3.02e-05	0.000124	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TGFBR2—esophageal cancer	3.01e-05	0.000124	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3e-05	0.000124	CbGpPWpGaD
Captopril—ALB—Metabolism—TYMP—esophageal cancer	2.94e-05	0.000121	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	2.9e-05	0.000119	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ADH7—esophageal cancer	2.89e-05	0.000119	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PLCE1—esophageal cancer	2.89e-05	0.000119	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—KDR—esophageal cancer	2.88e-05	0.000119	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.88e-05	0.000119	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP26A1—esophageal cancer	2.86e-05	0.000118	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SMAD4—esophageal cancer	2.85e-05	0.000117	CbGpPWpGaD
Captopril—F2—Hemostasis—PIK3CA—esophageal cancer	2.83e-05	0.000117	CbGpPWpGaD
Captopril—ALB—Metabolism—ALOX15—esophageal cancer	2.78e-05	0.000115	CbGpPWpGaD
Captopril—F2—Hemostasis—TP53—esophageal cancer	2.73e-05	0.000113	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NOTCH1—esophageal cancer	2.72e-05	0.000112	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ADH1B—esophageal cancer	2.69e-05	0.000111	CbGpPWpGaD
Captopril—ALB—Metabolism—GSTO1—esophageal cancer	2.65e-05	0.00011	CbGpPWpGaD
Captopril—ALB—Metabolism—TPI1—esophageal cancer	2.65e-05	0.00011	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.63e-05	0.000109	CbGpPWpGaD
Captopril—ABCB1—Metabolism—TYMP—esophageal cancer	2.57e-05	0.000106	CbGpPWpGaD
Captopril—ALB—Metabolism—ALDOB—esophageal cancer	2.54e-05	0.000105	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ADH1B—esophageal cancer	2.54e-05	0.000105	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	2.52e-05	0.000104	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP26A1—esophageal cancer	2.5e-05	0.000103	CbGpPWpGaD
Captopril—ALB—Hemostasis—NOS2—esophageal cancer	2.48e-05	0.000102	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	2.47e-05	0.000102	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CREBBP—esophageal cancer	2.46e-05	0.000102	CbGpPWpGaD
Captopril—ALB—Metabolism—GAPDH—esophageal cancer	2.45e-05	0.000101	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALOX15—esophageal cancer	2.44e-05	0.000101	CbGpPWpGaD
Captopril—ALB—Metabolism—CRABP1—esophageal cancer	2.43e-05	0.0001	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—TYMP—esophageal cancer	2.42e-05	0.0001	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP26A1—esophageal cancer	2.36e-05	9.73e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HIF1A—esophageal cancer	2.33e-05	9.61e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—TPI1—esophageal cancer	2.33e-05	9.6e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GSTO1—esophageal cancer	2.33e-05	9.6e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GNG7—esophageal cancer	2.31e-05	9.53e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALOX15—esophageal cancer	2.3e-05	9.48e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALDOB—esophageal cancer	2.23e-05	9.2e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KDR—esophageal cancer	2.23e-05	9.19e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—CREBBP—esophageal cancer	2.23e-05	9.18e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NOS3—esophageal cancer	2.21e-05	9.1e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GSTO1—esophageal cancer	2.19e-05	9.04e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—TPI1—esophageal cancer	2.19e-05	9.04e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	2.18e-05	8.98e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ALDH2—esophageal cancer	2.16e-05	8.93e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GAPDH—esophageal cancer	2.15e-05	8.86e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.14e-05	8.84e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CRABP1—esophageal cancer	2.13e-05	8.78e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALDOB—esophageal cancer	2.1e-05	8.67e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NOTCH1—esophageal cancer	2.1e-05	8.65e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.07e-05	8.55e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ERBB2—esophageal cancer	2.06e-05	8.51e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GSTT1—esophageal cancer	2.06e-05	8.49e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP2A6—esophageal cancer	2.03e-05	8.39e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.03e-05	8.36e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GNG7—esophageal cancer	2.02e-05	8.35e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GAPDH—esophageal cancer	2.02e-05	8.34e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CRABP1—esophageal cancer	2e-05	8.27e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—NOS3—esophageal cancer	1.99e-05	8.22e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ENO1—esophageal cancer	1.93e-05	7.96e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTGS1—esophageal cancer	1.93e-05	7.96e-05	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.93e-05	7.95e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GNG7—esophageal cancer	1.91e-05	7.87e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CREBBP—esophageal cancer	1.9e-05	7.85e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PSME2—esophageal cancer	1.9e-05	7.84e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PSME1—esophageal cancer	1.9e-05	7.84e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALDH2—esophageal cancer	1.9e-05	7.82e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—EGFR—esophageal cancer	1.87e-05	7.71e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCND1—esophageal cancer	1.82e-05	7.52e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GSTT1—esophageal cancer	1.8e-05	7.44e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALDH2—esophageal cancer	1.79e-05	7.37e-05	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PIK3CA—esophageal cancer	1.79e-05	7.37e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP2A6—esophageal cancer	1.78e-05	7.35e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CDKN1A—esophageal cancer	1.76e-05	7.27e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NOS3—esophageal cancer	1.7e-05	7.03e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GSTT1—esophageal cancer	1.7e-05	7.01e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTGS1—esophageal cancer	1.69e-05	6.97e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ENO1—esophageal cancer	1.69e-05	6.97e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.69e-05	6.97e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP2A6—esophageal cancer	1.68e-05	6.93e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EP300—esophageal cancer	1.68e-05	6.92e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PSME2—esophageal cancer	1.67e-05	6.87e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PSME1—esophageal cancer	1.67e-05	6.87e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.66e-05	6.85e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP1B1—esophageal cancer	1.64e-05	6.77e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PIK3CA—esophageal cancer	1.62e-05	6.69e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ERBB2—esophageal cancer	1.59e-05	6.57e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ENO1—esophageal cancer	1.59e-05	6.57e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTGS1—esophageal cancer	1.59e-05	6.57e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PSME1—esophageal cancer	1.57e-05	6.47e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PSME2—esophageal cancer	1.57e-05	6.47e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP19A1—esophageal cancer	1.54e-05	6.36e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—EP300—esophageal cancer	1.52e-05	6.25e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MYC—esophageal cancer	1.46e-05	6.03e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP1B1—esophageal cancer	1.44e-05	5.93e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EGFR—esophageal cancer	1.43e-05	5.9e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCND1—esophageal cancer	1.41e-05	5.81e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—HMOX1—esophageal cancer	1.41e-05	5.8e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.38e-05	5.69e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CDKN1A—esophageal cancer	1.36e-05	5.62e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP1B1—esophageal cancer	1.35e-05	5.59e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.35e-05	5.57e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ABCB1—esophageal cancer	1.35e-05	5.57e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EP300—esophageal cancer	1.3e-05	5.34e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP19A1—esophageal cancer	1.27e-05	5.25e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3CA—esophageal cancer	1.24e-05	5.12e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—HMOX1—esophageal cancer	1.23e-05	5.09e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TP53—esophageal cancer	1.2e-05	4.95e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—HMOX1—esophageal cancer	1.16e-05	4.79e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MYC—esophageal cancer	1.13e-05	4.66e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CA—esophageal cancer	1.12e-05	4.63e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ABCB1—esophageal cancer	1.12e-05	4.6e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EGFR—esophageal cancer	1.1e-05	4.56e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—TP53—esophageal cancer	1.08e-05	4.48e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.02e-05	4.21e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CA—esophageal cancer	9.58e-06	3.95e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TP53—esophageal cancer	9.27e-06	3.82e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CREBBP—esophageal cancer	9.03e-06	3.72e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—NOS3—esophageal cancer	8.08e-06	3.33e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CREBBP—esophageal cancer	7.91e-06	3.26e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CREBBP—esophageal cancer	7.45e-06	3.07e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTGS2—esophageal cancer	7.39e-06	3.05e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NOS3—esophageal cancer	7.08e-06	2.92e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NOS3—esophageal cancer	6.67e-06	2.75e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTGS2—esophageal cancer	6.48e-06	2.67e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—EP300—esophageal cancer	6.15e-06	2.54e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTGS2—esophageal cancer	6.1e-06	2.52e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—EP300—esophageal cancer	5.39e-06	2.22e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—EP300—esophageal cancer	5.08e-06	2.09e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CA—esophageal cancer	4.55e-06	1.88e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CA—esophageal cancer	3.98e-06	1.64e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CA—esophageal cancer	3.75e-06	1.55e-05	CbGpPWpGaD
